Four Drugs Included in the 2025 National Medical Insurance Drug Catalogue
December 8, 2025
Source: drugdu
42
Securities Daily Online News - On the evening of December 7, Betta Pharmaceuticals announced that the company's products, Icotinib Hydrochloride Tablets, Ensartinib Hydrochloride Capsules, Befotnib Mesylate Capsules, and Vorolanib Tablets, have been included in the National Essential Medical Insurance, Maternity Insurance and Work-Related Injury Insurance Drug Catalogue (2025).
https://finance.eastmoney.com/a/202512073584622051.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says December 11, 2025
- GLP-1 Medications Show Little Effect on Cancer, Study Shows December 11, 2025
- Qilu Pharmaceutical wins blockbuster new drug December 11, 2025
- Originating from traditional Chinese medicine, it defeated dapagliflozin head-to-head December 11, 2025
- Tencent invests in RNA innovative drug R&D company Hongxin Bio December 11, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
